Clinical Trial Update: A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial investigated the most effective dose of arformoterol for acute asthma; the study was terminated with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• arformoterol (arformoterol)

Snippet

Sponsor: Henry Ford Health System | Conditions: Acute Asthma | Phase 4 | Status: TERMINATED | Results posted: 2010-06-29